• Skip to primary navigation
  • Skip to content
  • Skip to footer
cannabinoid.data-1.science
  • Tags

    Neurodegenerative disease

    • Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
    • Endocannabinoid Metabolism and Traumatic Brain Injury (01 Sep 2022)
    • Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment (27 Aug 2022)
    • Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
    • New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders (07 Aug 2022)
    • The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation (05 Aug 2022)
    • Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (31 Jul 2022)
    • Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
    • Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)
    • Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (20 Jul 2022)

  • Feed